ReviewMetabolites2026

Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites.

Nobuyuki ToshikuniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.